9 Meters Biopharma Inc (NMTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -5,745 | -4,277 | -3,121 | -11,050 |
| Depreciation Amortization | 504 | 463 | 515 | 1,140 |
| Accounts receivable | 1,942 | 2,998 | 2,783 | N/A |
| Accounts payable and accrued liabilities | -261 | 1,425 | 1,861 | N/A |
| Other Working Capital | 3,858 | 2,583 | 4,846 | -740 |
| Other Operating Activity | -340 | -3,352 | -3,640 | 3,200 |
| Operating Cash Flow | $-42 | $-160 | $3,244 | $-7,450 |
| Cash Flows From Investing Activities | ||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $0 |
| Cash Flows From Financing Activities | ||||
| Change In Short Term Borrowing | 6,969 | 4,330 | 1,008 | N/A |
| Debt Issued | 1,645 | 1,645 | 1,645 | N/A |
| Common Stock Issued | 2,969 | 3,116 | N/A | N/A |
| Other Financing Activity | -11,584 | -8,922 | -5,882 | 7,540 |
| Financing Cash Flow | $-1 | $169 | $-3,229 | $7,540 |
| Beginning Cash Position | 97 | 97 | 97 | 1 |
| End Cash Position | 54 | 106 | 112 | 90 |
| Net Cash Flow | $-43 | $9 | $15 | $90 |
| Free Cash Flow | ||||
| Operating Cash Flow | -42 | -160 | 3,244 | -7,450 |
| Free Cash Flow | -42 | -160 | 3,244 | -7,450 |